A BILL 
To reauthorize the Stem Cell Therapeutic and Research Act 
of 2005, and for other purposes. 
Be it enacted by the Senate and House of Representa-
1
tives of the United States of America in Congress assembled, 
2
SECTION 1. SHORT TITLE. 
3
This Act may be cited as the ‘‘Timely ReAuthoriza-
4
tion of Necessary Stem-cell Programs Lends Access to 
5
Needed Therapies Act of 2019’’ or the ‘‘TRANSPLANT 
6
Act of 2019’’. 
7
20:49 Oct 28, 2019
H4764
2 
•HR 4764 IH
SEC. 2. REAUTHORIZATION OF THE C.W. BILL YOUNG CELL 
1
TRANSPLANTATION PROGRAM. 
2
(a) ADVISORY COUNCIL MEETINGS.—Subsection (a) 
3
of section 379 of the Public Health Service Act (42 U.S.C. 
4
274k) is amended by adding at the end the following new 
5
paragraph: 
6
‘‘(7) The Secretary shall convene the Advisory 
7
Council at least two times each calendar year.’’. 
8
(b) INCREASING COLLECTION.— 
9
(1) TECHNICAL CLARIFICATION.—Effective as 
10
if included in the enactment of Public Law 114–104 
11
(the Stem Cell Therapeutic and Research Reauthor-
12
ization Act of 2015), the amendment to section 
13
379(d)(2)(B) of the Public Health Service Act (42 
14
U.S.C. 274k(d)(2)(B)) in section 2(a)(2) of Public 
15
Law 114–104 is amended by inserting ‘‘goal of in-
16
creasing collections of high quality’’ before ‘‘cord 
17
blood units,’’. 
18
(2) ELIMINATING
DEADWOOD.—Subparagraph 
19
(B) of section 379(d)(2) of the Public Health Serv-
20
ice Act (42 U.S.C. 274k(d)(2)) is amended by strik-
21
ing the second and third sentences in such subpara-
22
graph. 
23
(c) PERIODIC REVIEW OF STATE OF SCIENCE.—Sec-
24
tion 379 of the Public Health Service Act (42 U.S.C. 
25
20:49 Oct 28, 2019
H4764
3 
•HR 4764 IH
274k) is amended by adding at the end the following new 
1
subsection: 
2
‘‘(o) PERIODIC REVIEW OF STATE OF SCIENCE.— 
3
‘‘(1) REVIEW.—Not less than every two years, 
4
the Secretary, in consultation with the Director of 
5
the National Institutes of Health, the Commissioner 
6
of Food and Drugs, the Administrator of the Health 
7
Resources and Services Administration, the Advisory 
8
Council, and other stakeholders, where appropriate 
9
given relevant expertise, shall conduct a review of 
10
the state of the science of using adult stem cells and 
11
birthing tissues to develop new types of therapies for 
12
patients, for the purpose of considering the potential 
13
inclusion of such new types of therapies in the Pro-
14
gram. 
15
‘‘(2) 
RECOMMENDATIONS.—Not 
later 
than 
16
June 30, 2024, the Secretary shall— 
17
‘‘(A) complete the second review required 
18
by paragraph (1); and 
19
‘‘(B) informed by such review, submit to 
20
the Committee on Health, Education, Labor, 
21
and Pensions of the Senate and the Committee 
22
on Energy and Commerce of the House of Rep-
23
resentatives recommendations on the appro-
24
20:49 Oct 28, 2019
H4764
4 
•HR 4764 IH
priateness of the inclusion of new types of 
1
therapies in the Program.’’. 
2
(d) AUTHORIZATION OF APPROPRIATIONS.—Section 
3
379B of the Public Health Service Act (42 U.S.C. 274m) 
4
is amended by striking ‘‘$33,000,000 for fiscal year 2015 
5
and $30,000,000 for each of fiscal years 2016 through 
6
2020’’ and inserting ‘‘$30,000,000 for each of fiscal years 
7
2021 through 2025’’. 
8
SEC. 3. CORD BLOOD INVENTORY. 
9
Subsection (g) of section 2 of the Stem Cell Thera-
10
peutic and Research Act of 2005 (42 U.S.C. 274k note) 
11
is amended to read as follows: 
12
‘‘(g) AUTHORIZATION
OF
APPROPRIATIONS.—To 
13
carry out this section, there is authorized to be appro-
14
priated $23,000,000 for each of fiscal years 2021 through 
15
2025.’’. 
16
Æ 
20:49 Oct 28, 2019
H4764
